$259 Million is the total value of Iron Triangle Partners LP's 26 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 82.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EHC | Buy | ENCOMPASS HEALTH CORP | $25,612,000 | -6.8% | 400,000 | +0.8% | 9.91% | +36.0% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $19,578,000 | -41.5% | 600,000 | -18.9% | 7.57% | -14.6% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $14,810,000 | -16.2% | 500,000 | +2.4% | 5.73% | +22.3% |
| NVRO | Buy | NEVRO CORP | $13,997,000 | +33.3% | 140,000 | +56.7% | 5.41% | +94.5% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $13,935,000 | -27.6% | 250,000 | -16.7% | 5.39% | +5.6% |
| MOH | New | MOLINA HEALTHCARE INC | $13,007,000 | – | 93,097 | +100.0% | 5.03% | – |
| CRL | New | CHARLES RIV LABS INTL INC | $12,621,000 | – | 100,000 | +100.0% | 4.88% | – |
| HUM | Sell | HUMANA INC | $12,561,000 | -42.9% | 40,000 | -33.3% | 4.86% | -16.6% |
| CHNG | New | CHANGE HEALTHCARE INC | $11,606,000 | – | 1,161,713 | +100.0% | 4.49% | – |
| TWST | Sell | TWIST BIOSCIENCE CORP | $11,530,000 | +13.6% | 377,040 | -22.0% | 4.46% | +65.9% |
| CTLT | New | CATALENT INC | $10,390,000 | – | 200,000 | +100.0% | 4.02% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $9,735,000 | – | 110,000 | +100.0% | 3.77% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $8,980,000 | – | 1,000,000 | +100.0% | 3.47% | – |
| MCK | Sell | MCKESSON CORP | $8,792,000 | -36.4% | 65,000 | -35.0% | 3.40% | -7.2% |
| BAX | New | BAXTER INTL INC | $8,119,000 | – | 100,000 | +100.0% | 3.14% | – |
| INOV | Sell | INOVALON HLDGS INC | $7,608,000 | -36.2% | 456,651 | -27.9% | 2.94% | -6.9% |
| HCA | Sell | HCA HEALTHCARE INC | $7,188,000 | -68.6% | 80,000 | -48.4% | 2.78% | -54.2% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $7,076,000 | -75.8% | 70,000 | -64.2% | 2.74% | -64.7% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $6,933,000 | -32.3% | 14,000 | -19.2% | 2.68% | -1.2% |
| SDGR | New | SCHRODINGER INC | $6,468,000 | – | 150,000 | +100.0% | 2.50% | – |
| HRTX | New | HERON THERAPEUTICS INC | $5,870,000 | – | 500,000 | +100.0% | 2.27% | – |
| DXCM | Sell | DEXCOM INC | $5,385,000 | -46.2% | 20,000 | -56.3% | 2.08% | -21.4% |
| AXNX | New | AXONICS MODULATION TECHNOLOG | $5,082,000 | – | 200,000 | +100.0% | 1.97% | – |
| BKD | New | BROOKDALE SR LIVING INC | $4,680,000 | – | 1,500,000 | +100.0% | 1.81% | – |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $4,167,000 | -7.2% | 150,000 | 0.0% | 1.61% | +35.6% | |
| GH | Sell | GUARDANT HEALTH INC | $2,784,000 | -75.3% | 40,000 | -72.3% | 1.08% | -64.0% |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -142,220 | -100.0% | -1.89% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -200,000 | -100.0% | -3.33% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -139,900 | -100.0% | -3.43% | – |
| RGEN | Exit | REPLIGEN CORP | $0 | – | -150,000 | -100.0% | -3.68% | – |
| CERN | Exit | CERNER CORPcall | $0 | – | -200,000 | -100.0% | -3.89% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -55,000 | -100.0% | -4.40% | – |
| NVST | Exit | ENVISTA HLDGS CORP | $0 | – | -596,064 | -100.0% | -4.68% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -82,500 | -100.0% | -7.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.